izumi.yoshida@metagentx.com We are thrilled to announce that Metagen Therapeutics’ Senior Scientific Advisor, Shinji Fukuda was selected as Highly Cited Researchers of 2024 by Clarivate Plc.
The Highly Cited Researchers list by Clarivate is an annual recognition of influential scientists and social scientists worldwide who have made broad and significant contributions to their fields. This year, Highly Cited Researcher 2024 awards were issued to 6,636 individuals.
Shinji Fukuda, Ph.D.
Co-Founder and Senior Scientific Advisor of Metagen Therapeutics
Dr. Fukuda, specially appointed professor at Keio University, Institute for Advanced Biosciences, specializes in environment control for intestinal microbiota. After receiving his Ph.D. in Agricultural Science, he completed his Special Postdoctoral Researcher in fundamental sciences at RIKEN Research Institute in Japan. In 2015, he established Metagen, Inc. as President and CEO, prior to founding Metagen Therapeutics.
For more information, please visit https://clarivate.com/news/clarivate-reveals-highly-cited-researchers-2024-list/